Besides, the small molecule roscovitine (seliciclib) inhibited CDKs 2 and 5 with suspending the proliferation of rapidly growing mammalian cancer cell lines with an IC50 value of 16 μM for CDK2 and induced growth arrest in G1-phase and accumulation in G2-phase [17,18,19]. This evidence concerns the gene CDK2 and cancer.